Alkem Laboratories Limited (BOM:539523)
India · Delayed Price · Currency is INR 5,360.00
+97.10 (1.84%)
At close: Oct 7, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 639.73 billion as of October 7, 2026. Its market cap has decreased by -2.61% in one year.
Market Cap
639.73B
Enterprise Value
624.88B
Revenue
150.81B
Ranking
n/a
PE Ratio
29.65
Stock Price
5,360.00
ChartMarket Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 639.73B, an increase of 287.24%. That is a compound annual growth rate of 13.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 639.73B | -2.83% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.81T |
| Dr. Reddy's Laboratories | 999.66B |
| Lupin | 927.73B |
| Abbott India | 570.16B |
| GlaxoSmithKline Pharmaceuticals | 470.02B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |